Cargando…
Bilirubin, a new therapeutic for kidney transplant?
In patients with end-stage renal disease, kidney transplantation has been associated with numerous benefits, including increased daily activity, and better survival rates. However, over 20% of kidney transplants result in rejection within five years. Rejection is primarily due to a hypersensitive im...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535229/ https://www.ncbi.nlm.nih.gov/pubmed/29983261 http://dx.doi.org/10.1016/j.trre.2018.06.003 |